Open AccessEfficacy and Safety of the Medium Cut-Off Elisio HX Dialyzer
Author(s) -
Francisco Maduell,
José Jesús Broseta,
Diana RodríguezEspinosa,
Jimena Del Risco-Zevallos,
Miquel Gómez,
Lida Rodas,
Marta AriasGuillén,
Manel Vera,
Néstor Fontseré,
María del Carmen Salgado,
Nayra Rico
Publication year - 2022
Publication title -
blood purification
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 57
eISSN - 1421-9735
pISSN - 0253-5068
DOI - 10.1159/000524644
Subject(s) - dialysis , albumin , hemodialysis , chemistry , in vivo , chromatography , dialysis adequacy , medicine , urology , microbiology and biotechnology , biology
The medium cut-off Elisio HX dialyzer by Nipro became commercially available in Europe in 2021, but there are still no reports of in vivo data. This study aimed to evaluate the safety and efficacy of it compared with previously evaluated hemodialysis (HD), expanded HD (HDx), and postdilution hemodiafiltration (HDF) treatments.